cerium has been researched along with Retinal Neovascularization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Kyosseva, SV; McGinnis, JF; Seal, S | 1 |
| Karakoti, AS; McGinnis, JF; Seal, S; Wong, LL; Zhou, X | 1 |
2 other study(ies) available for cerium and Retinal Neovascularization
| Article | Year |
|---|---|
Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.
Topics: Animals; Blotting, Western; Cerium; Cytokines; Disease Models, Animal; Female; Gene Expression Regulation; Intravitreal Injections; Male; Mice; Mice, Knockout; Oxidative Stress; Real-Time Polymerase Chain Reaction; Receptors, LDL; Retina; Retinal Neovascularization; Retinitis; RNA | 2013 |
Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse.
Topics: Animals; Cerium; Diabetic Retinopathy; Down-Regulation; Drug Evaluation, Preclinical; Eye; Intravitreal Injections; Macular Degeneration; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Mice, Knockout; Reactive Oxygen Species; Receptors, LDL; Retinal Neovascularization | 2011 |